230 publications
Organisation structure National Health Care Institute
Tisagenlecleucel-T (Kymriah®) for the treatment of ALL
Zorginstituut Nederland carried out an assessment of the medicinal product tisagenlecleucel-T (Kymriah®) for the treatment of ...
Lesinurad (Zurampic®) for the treatment of hyperuricaemia in gout patients
Zorginstituut Nederland carried out an assessment whether lesinurad (Zurampic®) is interchangeable with any product that is ...
Letermovir (Prevymis®) in cases of adult CMV-seropositive recipients of an allogenic haemotopoietic stem cell transplant (HSCT)
Zorginstituut Nederland has carried out an assessment whether letermovir (Prevymis®) is interchangeable with a medicinal product ...
Final report FAIR Data feasibility assessment
This is the final report of the FAIR Data part of the FAIR Data and Personal Health Train feasibility assessment. In this ...
Final report on the Personal Health Train feasibility assessment
This is the final report of the FAIR Data part of the feasibility assessment on FAIR Data & the Personal Health Train (PHT). In ...
Package advice in practice - Deliberations for arriving at a fair package
The public debate pays a lot of attention to how we can continue to pay for health care in the future. A question that the ...
Semaglutide (Ozempic®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
Zorginstituut Nederland carried out a marginal assessment of whether semaglutide (Ozempic®) is interchangeable with a drug ...
Working method for the Zinnige Zorg (appropriate care) Programme
Zorginstituut Nederland’s motto is "Taking care of good health care: no more and no less than necessary". Every citizen must be ...
Hydrocortisone sodium phosphate (Softacor®) for the treatment of mild non-infectious allergic or inflammatory conjunctival diseases
Zorginstituut Nederland has carried out an assessment of the medicinal product hydrocortisone sodium phosphate (Softacor®) can be ...